Chronotherapy applications in asthma and peptic ulcer disease MCQs With Answer

Introduction: Chronotherapy aligns drug administration with biological rhythms to maximize efficacy and minimize adverse effects. For M.Pharm students, understanding chronotherapy in asthma and peptic ulcer disease is essential because circadian variation strongly influences symptom severity, drug pharmacokinetics, and pharmacodynamics. Nocturnal asthma exacerbations and the night-time rise in gastric acid secretion present clear opportunities for time-tailored therapy. This quiz set explores mechanistic concepts (circadian biology, clock genes), clinical implications (optimal timing of beta2-agonists, inhaled corticosteroids, PPIs, H2 blockers), and formulation strategies (chronomodulated and pulsatile delivery). The questions emphasize evidence-based timing, therapeutic advantages, and formulation design considerations relevant to advanced pharmacology and patient-centered treatment planning.

Q1. What is the primary rationale for applying chronotherapy in asthma management?

• To reduce the dosing frequency irrespective of symptom timing
• To synchronize medication peak effect with predictable circadian worsening of airway inflammation and bronchoconstriction
• To minimize drug manufacturing costs by using sustained-release formulations
• To target genetic polymorphisms in drug-metabolizing enzymes

Correct Answer: To synchronize medication peak effect with predictable circadian worsening of airway inflammation and bronchoconstriction

Q2. Which circadian phenomenon most directly explains increased nocturnal asthma symptoms?

• Acrophase of cortisol coinciding with midnight
• Bathyphase of airway tone and heightened parasympathetic activity at night
• Peak plasma albumin levels during the night
• Increased hepatic blood flow at midnight

Correct Answer: Bathyphase of airway tone and heightened parasympathetic activity at night

Q3. For optimal control of nocturnal asthma, which inhaled corticosteroid dosing strategy is most supported by chronotherapy principles?

• Single morning dose of high-potency steroid
• Evening dosing or using a formulation that peaks during the night
• Alternating every other day dosing at noon
• Once-weekly very high dose in the morning

Correct Answer: Evening dosing or using a formulation that peaks during the night

Q4. Which drug class used in asthma shows clinically relevant chronopharmacokinetic differences favoring evening administration to control nocturnal symptoms?

• Short-acting muscarinic antagonists (SAMA)
• Long-acting beta2-agonists (LABA) with evening-timed dosing
• Systemic decongestants
• Oral antihistamines given in the morning

Correct Answer: Long-acting beta2-agonists (LABA) with evening-timed dosing

Q5. Which chronotherapeutic formulation approach is most appropriate to deliver anti-asthma medication to cover nocturnal exacerbations?

• Immediate-release tablet taken at breakfast
• Pulsatile release or delayed-release evening formulations that release drug several hours after ingestion
• Continuous infusion pump only during daytime
• Transdermal patch releasing drug only in the morning

Correct Answer: Pulsatile release or delayed-release evening formulations that release drug several hours after ingestion

Q6. Regarding theophylline chronotherapy, which statement is most accurate?

• Peak plasma theophylline concentrations should always occur in the morning to reduce nocturnal symptoms
• Timed-release theophylline formulations can be scheduled to provide higher plasma levels overnight when bronchoconstriction peaks
• Theophylline shows no circadian variation in effect, so timing is irrelevant
• Theophylline must be given only intravenously at night

Correct Answer: Timed-release theophylline formulations can be scheduled to provide higher plasma levels overnight when bronchoconstriction peaks

Q7. Which biomarker or measurement is most useful in assessing circadian control of asthma for chronotherapy planning?

• Fasting glucose
• 24-hour peak expiratory flow (PEF) diary showing nocturnal drops
• Serum creatinine clearance at a single time point
• Daytime blood pressure only

Correct Answer: 24-hour peak expiratory flow (PEF) diary showing nocturnal drops

Q8. In peptic ulcer disease (PUD), when does gastric acid secretion typically reach its nocturnal peak that guides chronotherapy?

• Early morning (dawn) and during the late night hours
• Midday after lunch only
• Immediately after breakfast exclusively
• Acid secretion is constant and without circadian variation

Correct Answer: Early morning (dawn) and during the late night hours

Q9. For once-daily proton pump inhibitor (PPI) therapy targeting night-time acid breakthrough, which dosing time is most appropriate according to chronotherapy principles?

• Bedtime dosing to suppress nocturnal acid secretion
• Random timing as long as absorption is adequate
• Administer immediately after a heavy lunch
• Once weekly high-dose morning administration

Correct Answer: Bedtime dosing to suppress nocturnal acid secretion

Q10. Which PPI pharmacodynamic characteristic makes timing of dosing relative to meals important?

• PPIs irreversibly inhibit active H+/K+-ATPase pumps, so dosing before the meal when pumps are active maximizes efficacy
• PPIs are activated by alkaline pH so should be given with antacids
• PPIs are only effective when taken with grapefruit juice
• PPIs bind to plasma albumin and require fasting to avoid competition

Correct Answer: PPIs irreversibly inhibit active H+/K+-ATPase pumps, so dosing before the meal when pumps are active maximizes efficacy

Q11. Which H2-receptor antagonist chronotherapy strategy can reduce nocturnal acid secretion effectively?

• Single low dose in the morning
• Higher dose administered at bedtime to target nocturnal acid rise
• Continuous topical application in the stomach
• Weekly intramuscular injection

Correct Answer: Higher dose administered at bedtime to target nocturnal acid rise

Q12. When designing a chronomodulated drug delivery system for PUD, which release profile best matches nocturnal acid secretion?

• Immediate release at breakfast only
• Lag-time followed by rapid drug release during late night/early morning
• Continuous low-level release that peaks at noon
• Release exclusively during daytime activity hours

Correct Answer: Lag-time followed by rapid drug release during late night/early morning

Q13. Which clinical trial endpoint is most appropriate to demonstrate benefit of chronotherapy in asthma?

• Change in fasting lipid profile
• Reduction in frequency/severity of nocturnal awakenings and overnight PEF variability
• Incidence of daytime headaches
• 24-hour urine output

Correct Answer: Reduction in frequency/severity of nocturnal awakenings and overnight PEF variability

Q14. Which molecular mechanism underlies circadian regulation relevant to chronotherapy?

• Stable expression of drug transporters without rhythmicity
• Transcription-translation feedback loops of clock genes (e.g., CLOCK, BMAL1, PER, CRY) that drive rhythmic physiology
• Permanent activation of all nuclear receptors at night
• Constant mitochondrial DNA replication throughout 24 hours

Correct Answer: Transcription-translation feedback loops of clock genes (e.g., CLOCK, BMAL1, PER, CRY) that drive rhythmic physiology

Q15. Which limitation must be considered when applying chronotherapy in clinical practice?

• All patients have identical circadian rhythms so personalization is unnecessary
• Interindividual variability in chronotype and adherence challenges may limit real-world effectiveness
• Chronotherapy eliminates all adverse effects permanently
• Timing has no interaction with pharmacokinetics

Correct Answer: Interindividual variability in chronotype and adherence challenges may limit real-world effectiveness

Q16. In H. pylori eradication regimens for peptic ulcer disease, how might chronotherapy principles be applied?

• Timing is irrelevant because antibiotics do not show time-dependent effects
• Administer acid-suppressive agents at night to optimize stomach pH and improve antibiotic stability/efficacy during critical nocturnal bacterial activity
• Give antibiotics only once weekly at any time
• Only probiotics require chronotherapeutic timing

Correct Answer: Administer acid-suppressive agents at night to optimize stomach pH and improve antibiotic stability/efficacy during critical nocturnal bacterial activity

Q17. Which patient factor should be assessed before implementing chronotherapy for asthma or PUD?

• Patient chronotype (morningness/eveningness), sleep patterns, and adherence capability
• Only the patient’s blood type
• Number of owned pets
• Height in centimeters exclusively

Correct Answer: Patient chronotype (morningness/eveningness), sleep patterns, and adherence capability

Q18. Which is a proven benefit of evening-dosed long-acting inhaled corticosteroids in patients with nocturnal asthma?

• Complete cure of asthma after one week
• Improved overnight lung function and reduced nocturnal symptoms compared with morning dosing in some studies
• Higher daytime sedation compared to placebo
• Increased nocturnal gastric acidity

Correct Answer: Improved overnight lung function and reduced nocturnal symptoms compared with morning dosing in some studies

Q19. Which chronotherapeutic delivery technology is specifically engineered to release drug after a predetermined lag time?

• Immediate-release matrix tablet
• Time-dependent (lag-time) pulsatile release system
• Continuous intravenous infusion pump without timing control
• Orally disintegrating tablet for rapid buccal absorption

Correct Answer: Time-dependent (lag-time) pulsatile release system

Q20. Which outcome would most strongly support adoption of chronotherapy for PUD in clinical guidelines?

• Demonstration that timed therapy improves healing rates, reduces nocturnal reflux symptoms, and lowers rebleeding rates compared with conventional timing
• Only improved patient satisfaction with pill color
• Increased manufacturing profit for pharmaceutical companies
• Shorter hospital stay for unrelated surgical procedures

Correct Answer: Demonstration that timed therapy improves healing rates, reduces nocturnal reflux symptoms, and lowers rebleeding rates compared with conventional timing

Download